Ztalmy, the commercial-stage rare neurology medicine, is approved by in the U.S. the European Union, the United Kingdom and China, with potential for further approvals worldwide, Immedica said in ...

For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials ...